We are live on ! Find out more
CLLS

Cellectis
CLLS

39 hedge funds and large institutions have $160M invested in Cellectis in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

3% more funds holding

Funds holding: 38 → 39 (+1)

10% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 10

13% less capital invested

Capital invested by funds: $184M → $160M (-$24.5M)

43% less call options, than puts

Call options by funds: $8K | Put options by funds: $14K

Holders
39
Holders Change
+1
Holders Change %
+2.63%
% of All Funds
1.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
9
Reduced
10
Closed
5
Calls
$8K
Puts
$14K
Net Calls
-$6K
Net Calls Change
-$6K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$1.55M
2
Deutsche Bank
Deutsche Bank
Germany
+$1.17M
3
GH
GAM Holding
Switzerland
+$1.03M
4
BIT
BlackRock Institutional Trust
California
+$455K
5
ACA
Avoro Capital Advisors
New York
+$418K

Top Sellers

Rank Fund Capital Flow
1
LCM
Landscape Capital Management
New Jersey
-$1.58M
2
AG
Artal Group
Luxembourg
-$1.57M
3
CWM
Cabot Wealth Management
Massachusetts
-$843K
4
TAM
Tocqueville Asset Management
New York
-$734K
5
CCP
Clough Capital Partners
Massachusetts
-$476K

CLLS Hedge Fund Activity: Q3 2016 in Review

39 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Cellectis (CLLS) for Q3 2016, worth a combined $160M — down 13% from $184M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new CLLS positions and 5 closed out — a net gain of 2 holders — while 9 added to existing stakes and 10 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $1.55M. The largest seller was Landscape Capital Management, cutting an estimated $1.58M.

  • 39 institutional investors held Cellectis (CLLS) as of Q3 2016, up from 38 in Q2 2016.
  • Funds reported $160M of Cellectis stock for Q3 2016, down 13% quarter-over-quarter.
  • 7 funds opened new Cellectis positions in Q3 2016 and 5 closed out, a net change of +2 holders.
  • The largest Cellectis buyer in Q3 2016 was Morgan Stanley, an estimated $1.55M added.
  • The largest Cellectis seller in Q3 2016 was Landscape Capital Management, an estimated $1.58M sold.

Based on aggregated 13F filings for Q3 2016.